Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1973;41:443-446
© 1973 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KANTOR, H. I.
Right arrow Articles by KAYE, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KANTOR, H. I.
Right arrow Articles by KAYE, H. L.

Clear Cell Adenocarcinoma in Young Women

HERMAN I. KANTOR, MD, FACOG, SHELDON A. WEINSTEIN, MD, FACOG and HAROLD L. KAYE, MD

From the Obstetrics-Gynecological Service at the Presbyterian Hospital, Dallas, Tex 75231

Abstract

Two young patients who developed clear cell adenocarcinoma arc reported. In both, their mothers received diethylstilbcslrol (DES) during pregnancy. Treatment of the problem is discussed. Only by reporting additional cases seen by physicians can the etiologic association he strengthened. Since the administration of DES during pregnancy was once quite popular, it seems that many more young women with this type of adenocarcinoma should be seen. Future investigations will either strengthen or weaken this possible ctinlogic association.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American College of Obstetricians and Gynecologists.